Ticker: CBPO, Company: China Biologic Products Holdings, Inc., Type: SC 13E3/A, Date: 2020-02-19
Original SEC Filing: Click here

---

Webplus: CBPO/20200219/SC_13E3.A_1/2_EX-99.(D)(1)/000.htm SEC Original: tm207907d3_ex-d1.htm
Preliminary Non-binding Proposal to Acquire China Biologic Products Holdings, Inc. September 18, 2019 The Board of Directors China Biologic Products Holdings, Inc. 18th Floor, Jialong International Building, 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China Dear Sirs: Consortium Members Consortium Company Acquisition Beachhead Holdings Limited, CITIC Capital China Partners IV, L.P., PW Medtech Group Limited, Parfield

---

---

Webplus: CBPO/20200219/SC_13E3.A_1/3_EX-99.(D)(2)/000.htm SEC Original: tm207907d3_ex-d2.htm
PREVILEDGED AND CONFIDENTIAL Execution Version CONSORTIUM AGREEMENT Agreement Centurium 普华和顺集团公司 PWM CITIC Parfield Hillhouse Temasek Initial Consortium Members Party Parties This CONSORTIUM AGREEMENT (this “ Transaction Company Buyer Consortium WHEREAS, the Parties propose to undertake an acquisition transaction (the “ Holdco Merger Sub Closing WHEREAS, (a) in connection with the Transaction, the Parties propose to form a new company (“

---

---

Webplus: CBPO/20200219/SC_13E3.A_1/4_EX-99.(D)(3)/000.htm SEC Original: tm207907d3_ex-d3.htm
Execution Version AMENDMENT NO. 1 TO CONSORTIUM AGREEMENT Amendment Beachhead Double Double Point Forward Centurium 普华和顺集团公司 PWM CITIC Parfield Hillhouse Temasek, Parties Party This AMENDMENT NO. 1 TO CONSORTIUM AGREEMENT, dated as of January 23, 2020 (this “ Original Consortium Agreement Consortium Agreement Company WHEREAS, on September 18, 2019, Beachhead, PWM, CITIC, Parfield, Hillhouse and Temasek entered into a consortium

---

---

Webplus: CBPO/20200219/SC_13E3.A_1/5_EX-99.(D)(4)/000.htm SEC Original: tm207907d3_ex-d4.htm
STRICTLY CONFIDENTIAL Execution Version SHARE PURCHASE AGREEMENT Agreement Seller Purchaser Party Parties This SHARE PURCHASE AGREEMENT, dated as of September 18, 2019 (this “ WHEREAS, the Seller is the owner of 6,321,000 Ordinary Shares of the Issuer; Sale Shares WHEREAS, the Seller has agreed to sell to the Purchaser, and the Purchaser has agreed to purchase from the Seller, all

---

---

Webplus: CBPO/20200219/SC_13E3.A_1/6_EX-99.(D)(5)/000.htm SEC Original: tm207907d3_ex-d5.htm
STRICTLY CONFIDENTIAL Executive Version SHARE PURCHASE AGREEMENT Agreement Parfield Amplewood, Seller Purchaser Party Parties This SHARE PURCHASE AGREEMENT, dated as of September 18, 2019 (this “ WHEREAS, Parfield is the owner of 2,682,742 Ordinary Shares of the Issuer and Amplewood is the owner of 454,954 Ordinary Shares of the Issuer; WHEREAS, the Seller has agreed to sell to the Purchaser,

---

---

Webplus: CBPO/20200219/SC_13E3.A_1/7_EX-99.(D)(6)/000.htm SEC Original: tm207907d3_ex-d6.htm
Execution Version SHARE PURCHASE AGREEMENT Agreement Seller Purchaser Parties Party This SHARE PURCHASE AGREEMENT, dated as of January 23, 2020 (this “ CITIC Proposal WHEREAS, on September 18, 2019, the Seller, CITIC Capital China Partners IV, L.P. (“ Consortium Agreement Sale Shares WHEREAS, the Seller has agreed to sell to the Purchaser, and the Purchaser has agreed to purchase from

---

---

Webplus: CBPO/20200219/SC_13E3.A_1/8_EX-99.(D)(7)/000.htm SEC Original: tm207907d3_ex-d7.htm
Execution Version SHARE PURCHASE AGREEMENT Agreement Seller Purchaser Parties Party This SHARE PURCHASE AGREEMENT, dated as of January 23, 2020 (this “ Proposal WHEREAS, on September 18, 2019, the Seller, the Purchaser and certain other parties submitted a non-binding proposal to acquire the Issuer (the “ Consortium Agreement Sale Shares WHEREAS, the Seller has agreed to sell to the Purchaser,

---

---

Webplus: CBPO/20200219/SC_13E3.A_1/9_EX-99.(D)(8)/000.htm SEC Original: tm207907d3_ex-d8.htm
Execution Version SHARE PURCHASE AGREEMENT Agreement Seller Purchaser Parties Party This SHARE PURCHASE AGREEMENT, dated as of January 23, 2020 (this “ Proposal WHEREAS, on September 18, 2019, the Seller, the Purchaser and certain other parties submitted a non-binding proposal to acquire the Issuer (the “ Consortium Agreement Sale Shares WHEREAS, the Seller has agreed to sell to the Purchaser,

---

---

Webplus: CBPO/20200219/SC_13E3.A_1/1/000.htm SEC Original: tm207907d3_sc13e3a.htm

---

Company Info:

Ticker: CBPO, Company: China Biologic Products Holdings, Inc., Type: SC 13E3/A, Date: 2020-02-19CIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING, 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT
BEIJING 100125